876062-71-4

Basic information

• Product Name: Spiro[1,3-dioxolane-2,6'(5'H)-[2H]naphtho[1,2-b]pyran]-5'-one, 3',4'-dihydro-4-(hydroxymethyl)-2',2'-dimethyl-
• CAS NO: 876062-71-4
• Molecular Formula: C18H20O5
• Molecular Weight: 316.354
• Mol File: 876062-71-4.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: Spiro[1,3-dioxolane-2,6'(5'H)-[2H]naphtho[1,2-b]pyran]-5'-one, 3',4'-dihydro-4-(hydroxymethyl)-2',2'-dimethyl-(CAS DataBase Reference)
• NIST Chemistry Reference: Spiro[1,3-dioxolane-2,6'(5'H)-[2H]naphtho[1,2-b]pyran]-5'-one, 3',4'-dihydro-4-(hydroxymethyl)-2',2'-dimethyl-(876062-71-4)
• EPA Substance Registry System: Spiro[1,3-dioxolane-2,6'(5'H)-[2H]naphtho[1,2-b]pyran]-5'-one, 3',4'-dihydro-4-(hydroxymethyl)-2',2'-dimethyl-(876062-71-4)

Safety Data

• Hazardous Substances Data: 876062-71-4(Hazardous Substances Data)

Upstream product

• 4707-32-8 2,2-dimethyl-3,4-dihydro-2H-benzo[h]chromene-5,6-dione 
• 56-81-5 glycerol 

Relevant articles and documents

Pharmaceutical compositions of beta-lapachone and beta-lapachone analogs with improved tumor targeting potential

The present invention relates to polymer-modified quinone-containing and carbonyl-containing therapeutic agents, including polymer-modified β-lapachone compounds, and methods of treating cancer by administering the polymer-modified therapeutic agents to a subject. Polymer-modification of therapeutic agents, such as β-lapachone compounds, provides effective transport of polymer-modified therapeutic agents to tumor cells or tumor tissues by exploiting the EPR effect in tumor tissues.